导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 45.70% | 51/1050 |
| 近一周 | -1.88% | 351/1104 |
| 近一月 | -2.84% | 329/1102 |
| 近一季 | -13.91% | 809/1092 |
| 近半年 | 34.91% | 51/1070 |
| 近一年 | 55.41% | 61/1018 |
| 近两年 | 192.23% | 61/926 |
| 近三年 | 196.05% | 25/834 |
| 成立以来 | 347.84% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
7.63% 76/1070 |
77.10% 124/1101 |
- - |
- - |
| 2025 | 82.51% 35/1065 |
0.86% 730/1014 |
3.19% 422/1038 |
66.66% 17/1050 |
5.21% 131/1065 |
| 2024 | 14.64% 183/1011 |
0.01% 312/960 |
11.85% 5/983 |
8.77% 734/991 |
-5.78% 716/1011 |
| 2023 | -13.13% 440/952 |
6.60% 234/880 |
-2.96% 372/895 |
-11.79% 672/915 |
-4.79% 480/952 |
| 2022 | -23.14% 442/867 |
-17.91% 422/773 |
14.95% 120/806 |
-4.85% 63/845 |
-14.40% 830/867 |
| 2021 | 12.94% 208/740 |
-10.76% 504/580 |
26.10% 72/659 |
0.25% 211/704 |
0.11% 435/740 |
| 2020 | 84.98% 75/554 |
13.06% 26/419 |
43.25% 13/466 |
1.20% 408/517 |
12.86% 256/554 |
| 2019 | - - |
- - |
-0.10% 352/1228 |
22.21% 12/390 |
16.42% 33/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 富国互联科技股票A VS. 东吴新产业精选股票A(580008) |